2799A Hae Tender in Norway - 147956024

Procurement Summary

Country: Norway

Summary: 2799A Hae

Deadline: 01 Oct 2026

Posting Date: 26 Aug 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 147956024

Document Ref. No.: 588716-2026

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

CPV Classification

33000000 - Medical equipments, pharmaceuticals and personal care products
33600000 - Pharmaceutical products

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_details

Login to see details

Tender Details

2799a HAE
The contracting authority for this competition is Sykehusinnkjøp HF, on behalf of the four regional health authorities in Norway: Helse Sør-Øst RHF, Helse Vest RHF, Helse Midt-Norway RHF and Helse Nord RHF. The contracting authority shall, on behalf of the four regional health authorities in Norway enter into framework agreements for the procurement of medicines with active ingredient for heriditarian angioedema (HAE) disease. The procurement includes the following ATC groups: B06AC01 - C1 inhibitor B06AC02 - Ikatibant B06AC04 - Konestat alfa B06AC05 - Lanadelumab B06AC06 - Beroltral state B06AC07 - Garadacimab B06AC08 - Sebetral state B06AC09 - Donidalorsen See Annex 3 Requirement Specifications and The Competition Provisions for detailed information.
Doc Title: 2799a HAE
Contract Type: supplies
Document Type: Contract Notice

Contract Type: supplies

Authority Type: pub-undert

Doc Title: 2799a HAE

Dispatch Date: 2026-08-24

Publish Date: 2026-08-26

Submission Date: 2026-10-01

Documents

 Tender Notice